Get the Stockscreener App
203.19
5.51%
10.61
After Hours:
203.36
0.17
+0.08%
Penumbra Inc stock is traded at $203.19, with a volume of 385.36K.
It is up +5.51% in the last 24 hours and up +0.43% over the past month.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
See More
Previous Close:
$192.58
Open:
$193.7
24h Volume:
385.36K
Relative Volume:
0.86
Market Cap:
$7.89B
Revenue:
$1.13B
Net Income/Loss:
$14.23M
P/E Ratio:
197.27
EPS:
1.03
Net Cash Flow:
$110.67M
1W Performance:
+4.34%
1M Performance:
+0.43%
6M Performance:
-8.66%
1Y Performance:
-5.74%
1-Day Range:
$193.50
$203.86
1-Week Range:
$190.08
$203.86
52-Week Range:
$148.00
$277.34
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Get Out the Clot Campaign Brings Together Leaders and Experts to Improve Patient Care for Venous Thromboembolism - StockTitan
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Penumbra, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm - Marketscreener.com
Here's Why You Should Retain Penumbra Stock in Your Portfolio Now - Yahoo Finance
Royal Bank of Canada Raises Penumbra (NYSE:PEN) Price Target to $222.00 - MarketBeat
Critical Insights From Penumbra Analyst Ratings: What You Need To Know - Benzinga
Penumbra, Inc.'s (NYSE:PEN) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? - Yahoo Finance
Insider Sale: EVP, General Counsel & Secretary Johanna Roberts S - GuruFocus.com
Director Harpreet Grewal Sells Shares of Penumbra Inc (PEN) - GuruFocus.com
Penumbra, Inc. (NYSE:PEN) Director Sells $31,677.78 in Stock - MarketBeat
Penumbra EVP Johanna Roberts sells over $114k in company stock By Investing.com - Investing.com South Africa
Penumbra director Kassing sells shares worth over $32k - Investing.com India
Penumbra director Kassing sells shares worth over $32k By Investing.com - Investing.com Canada
Penumbra director Kassing sells shares worth over $32k By Investing.com - Investing.com South Africa
Penumbra director Kassing sells shares worth over $32k By Investing.com - Investing.com Australia
Penumbra director sells shares worth over $31,000 By Investing.com - Investing.com South Africa
Penumbra director sells shares worth over $31,000 By Investing.com - Investing.com Canada
Penumbra director sells shares worth over $31,000 - Investing.com
PENPenumbra, Inc. Latest Stock News & Market Updates - StockTitan
Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024 - Longview News-Journal
Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024 - StockTitan
Where are the Opportunities in (PEN) - Stock Traders Daily
Clearbridge Investments LLC Sells 12,675 Shares of Penumbra, Inc. (NYSE:PEN) - MarketBeat
PEN Stock to Gain From CE Mark Approval for its CAVT Technologies - MSN
Penumbra's SWOT analysis: stock faces headwinds amid long-term growth potential - Investing.com India
Algert Global LLC Has $5.06 Million Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra's SWOT analysis: stock faces headwinds amid long-term growth potential - Investing.com
Hsbc Holdings PLC Increases Stock Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Marshall Wace LLP Increases Stock Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Envestnet Asset Management Inc. Raises Holdings in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Canada Pension Plan Investment Board Has $5.89 Million Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Bavarian Nordic secures additional $63m order in US for Jynneos production - World Pharmaceutical Frontiers
PEN (Penumbra) GF Score : 87/100 (As of Sep. 25, 2024) - GuruFocus.com
Bavarian Nordic gets $63 million US government order or small pox, mpox vaccine - Bahrain News Agency
Vanguard Personalized Indexing Management LLC Grows Stock Holdings in Penumbra, Inc. (NYSE:PEN) - Defense World
Bavarian Nordic gains US contract for additional mpox vaccine - Pharmaceutical Technology
Penumbra CEO Adam Elsesser sells over $2.9 million in company stock By Investing.com - Investing.com South Africa
Penumbra CEO Adam Elsesser sells over $2.9 million in company stock - Investing.com
Penumbra CEO Adam Elsesser sells over $2.9 million in company stock - Investing.com UK
Bavarian Nordic said to have won $63M mpox vaccine contract from U.S. - Seeking Alpha
Bavarian Nordic gets $63 million US government order for small pox, mpox vaccine By Reuters - Investing.com
Bavarian Nordic Secures $63 Million U.S. Government Contract for Vaccine Production - Devdiscourse
Bavarian Nordic gets $63 million US government order for small pox, mpox vaccine - Yahoo! Voices
Penumbra, Inc. (NYSE:PEN) Stock Position Raised by First Light Asset Management LLC - MarketBeat
Intech Investment Management LLC Makes New $3.59 Million Investment in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra Inc (PEN) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Penumbra, Inc. (NYSE:PEN) Shares Sold by Mutual of America Capital Management LLC - Defense World
64,782 Shares in Penumbra, Inc. (NYSE:PEN) Acquired by Skandinaviska Enskilda Banken AB publ - MarketBeat
When the Price of (PEN) Talks, People Listen - Stock Traders Daily
Twin studies show Bavarian Nordic’s Mpox vax efficacy wanes in 1 year - Yes Punjab
Twin studies show Bavarian Nordic’s Mpox vax efficacy wanes in 1 year - Newsroom Odisha
Why Is Penumbra (PEN) Up 20% Since Last Earnings Report? - MSN
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):